Elias E, Uhanova J, Minuk G
Can Liver J. 2022; 3(2):177-187.
PMID: 35991855
PMC: 9202790.
DOI: 10.3138/canlivj.2019-0006.
Inamine T, Schnabl B
J Gastroenterol. 2017; 53(6):691-700.
PMID: 29075899
PMC: 5971039.
DOI: 10.1007/s00535-017-1400-8.
Yang J, Yang L, Li B, Zhou W, Zhong S, Zhuang Z
Biomed Res Int. 2016; 2016:3290260.
PMID: 28025641
PMC: 5153474.
DOI: 10.1155/2016/3290260.
Inamine T, Yang A, Wang L, Lee K, Llorente C, Schnabl B
Alcohol Clin Exp Res. 2016; 40(12):2604-2613.
PMID: 27739086
PMC: 5133156.
DOI: 10.1111/acer.13239.
Bekesova S, Kosti O, Chandler K, Wu J, Madej H, Brown K
J Proteomics. 2012; 75(7):2216-24.
PMID: 22326963
PMC: 3568703.
DOI: 10.1016/j.jprot.2012.01.024.
IgA against gut-derived endotoxins: does it contribute to suppression of hepatic inflammation in alcohol-induced liver disease?.
Parlesak A, Schafer C, Bode C
Dig Dis Sci. 2002; 47(4):760-6.
PMID: 11991606
DOI: 10.1023/a:1014783815433.
Clinical study of IgA antibody against hepatitis C virus core antigen in patients with type C chronic liver disease.
Tanaka M, Sato S, Fujiyama S, Kawano S, Taura Y, Chikazawa H
Dig Dis Sci. 1995; 40(2):457-64.
PMID: 7531636
DOI: 10.1007/BF02065435.
IgM and IgA antibodies generated against hepatitis C virus core antigen in patients with acute and chronic HCV infection.
Sato S, Fujiyama S, Tanaka M, Goto M, Taura Y, Kawano S
Dig Dis Sci. 1994; 39(9):2022-31.
PMID: 7521823
DOI: 10.1007/BF02088141.
Hyperglobulinemia in alcoholic cirrhosis. Relationship with portal hypertension and intrahepatic portal-systemic shunting as assessed by Kupffer cell uptake.
Pomier-Layrargues G, Huet P, Richer G, Marleau D, VIALLET A
Dig Dis Sci. 1980; 25(7):489-93.
PMID: 7389537
DOI: 10.1007/BF01315210.
IgA in alcoholic cirrhosis.
Kalsi J, Delacroix D, Hodgson H
Clin Exp Immunol. 1983; 52(3):499-504.
PMID: 6872315
PMC: 1536036.
[Kidney involvement in liver diseases: morphology].
Syre G
Klin Wochenschr. 1983; 61(20):1049-51.
PMID: 6645305
DOI: 10.1007/BF01537503.
Relation of immune response to development of central nervous system lesions in virus infections of man.
Webb H, Smith C
Br Med J. 1966; 2(5523):1179-81.
PMID: 5331895
PMC: 1944699.
DOI: 10.1136/bmj.2.5523.1179.
[Quantitative behavior of immunoglobulins in chronic inflammatory liver diseases].
Schumacher K, Gross R
Klin Wochenschr. 1969; 47(3):123-9.
PMID: 4983893
DOI: 10.1007/BF01746045.
[Significance of immunologic reactions for the diagnosis and pathogenesis of chronic hepatitis].
Schumacher K
Klin Wochenschr. 1969; 47(18):949-59.
PMID: 4913990
DOI: 10.1007/BF01498231.
A study on the relationship of porphyria cutanea tarda and liver damage.
Horkay I, PREKOPA A, Dalmy L, Dan S, TAMASI P
Arch Dermatol Forsch. 1973; 247(3):235-43.
PMID: 4748769
DOI: 10.1007/BF00596242.
Serum immunoglobulin levels in Australia antigen positive and Australia antigen negative hepatitis.
Peters C, Johnson K
Clin Exp Immunol. 1972; 11(3):381-91.
PMID: 4625396
PMC: 1553662.
Clinical implications of monoclonal gammopathy in chronic liver disease.
Slavin S, Zlotnick A, LEVIJ I, Eliakim M
Am J Dig Dis. 1974; 19(3):223-34.
PMID: 4363471
DOI: 10.1007/BF01072539.
[Significance of immunoglobulins for the diagnosis and evaluation of the course of liver diseases].
Lamerz R, Eisenburg J, KNEDEL M
Klin Wochenschr. 1969; 47(3):129-40.
PMID: 4189684
DOI: 10.1007/BF01746046.
Immunoglobulin-containing cells in the liver.
Hadziyannis S, Feizi T, Scheuer P, Sherlock S
Clin Exp Immunol. 1969; 5(5):499-514.
PMID: 4188217
PMC: 1579146.
Agglutinating factor in serum of patients with viral hepatitis.
Risemberg A, De Gomez A, Rife U
Ann Rheum Dis. 1969; 28(4):428-30.
PMID: 4183307
PMC: 1010512.
DOI: 10.1136/ard.28.4.428.
